A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
UCSF Chancellor Susan Desmond-Hellmann spoke with The Wall Street Journal reporter Amy Marcus about her vision of a “new social contract” for patients participating in the health care system.
A new UCSF Medical Center study finds that publicly reported “hospital readmission rates” often reflect problems like hospital-acquired infections or complications from surgery that may be misleading to patients.